R
Randomized clinical trial. See clinical trials
Rawling, Alison, 389 n.8
Ray, Laurence J., 377 n.165
Reagan administration, 221
regulation, of pharmaceutical drugs, 339 -40. See also FDA; treatment activism
regulatory science, 277
Relman, Arnold, 258
researchers: vs . doctors, 255 , 432 n.65
respect for activists, 337 -39
research on AIDS. See AIDS research
resource mobilization, 20 , 365 n.41
Restivo, Sal, 422 n.91
Rethinking AIDS (Root-Bernstein), 169
retinitis, 235
Retinitis Pigmentosa Society (Germany), 10
Retrovir. See AZT
retroviral hypothesis. See viral hypothesis
retroviruses, 183
cancer-causing, 105
Duesberg on, 107
suspected as cause of AIDS, 69 -71. See also ARV; HIV-1; HTLV; LAV
Reuters, 150
Reuters Financial Report , 151
reverse transcriptase, 295
ribavirin (antiviral drug), 188
ribonucleic acid (RNA), 67
Richards, Evelleen, 128 , 367 n.67, 375 n.147, 433 n.91, 437 n.3, 442 n.3
on clinical trials, 343
Richman, Douglas, 284
ACTG 266
on ACTG 314
on activists, 338
on AZT, 311
on clinical trials, 249
on Concorde trial, 333 -34
Rier, David, 368 n.80, 376 n.161
on autonomy of AIDS patients, 206
on grassroots AIDS publications, 195
on resource mobilization, 20
on spread of knowledge, 23
right-wing support of Duesberg, 158 -59
risk: autonomy of patients, 222
and regulatory science, 35 -38
risk-AIDS hypothesis, 131 -37
risk groups, 134 -35, 364 n.33. See also specific groups
ritonavir, 324
RNA (ribonucleic acid), 67
Roland, Michelle, 257
on activists, 343
on clinical-trial design, 248
on doctors, 347
Rolston, Adam, 377 n.167, 414 n.41, 416 n.71
Root-Bernstein, Robert, 143
credibility of, 156
Discovering , 153
Rethinking AIDS , 169
Rosenberg, Charles, 40 , 362 n.12, 381 n.20, 383 n.35
Rothman, David, 215 , 362 n.18, 379 n.174, 411 n.79
on ethics of clinical research, 190
RSI (Repetitive Strain Injury) Association (United Kingdom), 10
Ruzek, Sheryl, 10
Ryan, Thomas, 160